利用植物衍生的纳米微粒来进行基于核酸的先进基因疗法
Meihong Chai1, Bowen Gao2, Shihua Wang3
1Xi'an Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710021, China.
Theranostics
|January 2, 2025
概括
植物衍生纳米纤维 (PDNVs) 为核酸疗法提供了一种新型的输送系统,增强遗传疾病的稳定性和有效性. 这种方法使基因疗法超越了传统的基因修复,用于癌症等疾病.
科学领域:
- 生物技术和基因工程 生物技术和基因工程
- 纳米医学和药物输送系统
背景情况:
- 基因疗法正在发展,超越了对遗传疾病的直接基因修复.
- 核酸疗法 (mRNA,miRNA,siRNA,DNA) 在不改变遗传序列的情况下调节蛋白质表达.
研究的目的:
- 审查植物衍生纳米纤维 (PDNV) 作为核酸治疗的输送系统的创新性使用.
- 突出PDNVs在提高治疗核酸的稳定性,生物可用性,特异性和疗效方面的潜力.
主要方法:
- 关于植物衍生纳米纤维 (PDNVs) 的当前文献的综述.
- 分析PDNV特性及其在提供基于核酸的治疗药物中的应用.
- 检查PDNVs在克服传统基因疗法传递方法的局限性方面的作用.
主要成果:
- PDNV增强了治疗性核酸的稳定性和生物可用性.
- 在目标应用中,PDNVs提高了核酸疗法的特异性和有效性.
- PDNV显示出治疗癌症和炎症等疾病的潜力.
结论:
- 植物衍生的纳米纤维 (PDNVs) 是基因治疗的有前途的进步.
- 基于PDNV的核酸疗法为治疗遗传和其他疾病提供了变革的潜力.
- 这种方法扩大了基因治疗的范围,使得功能性遗传物质的传递能够在不改变遗传序列的情况下实现.
更多相关视频
06:26Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
928
09:23Delivery of the Cas9/sgRNA Ribonucleoprotein Complex in Immortalized and Primary Cells via Virus-like Particles "Nanoblades"
Published on: March 31, 2021
4.8K
相关概念视频
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
